2021 - IHE

Olofsson S, Gralén K, Hoxer C, Okhuoya, P, Persson U The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study The European Journal of Health Economics, 2022;23(6): 993-1005
DOI: https://doi.org/10.1007/s10198-021-01415-9
Hofmarcher T, Ahmad A, Lindgren P, Wilking N Cancer Care in the Middle East and Africa IHE Report 2021:9, IHE: Lund, Sweden
Blay J-Y, Dillion A, O’Rourke B, Persson U, Pickaert A-P When Precision Meets Decision: It Is Time to Evolve Current Approaches to Health Technology Assessments for the Evaluation of Precision Oncology Therapeutics Health Intelligence Report 2021, Shift Health: Toronto, Canada
Norlin J M, Hjalte F, Kellerborg K, Odin P When Increasing Severity of Parkinson’s Disease Leads to Increasing Costs: Results From Register-Based Research in a Swedish Setting Value & Outcomes Spotlight, SEPTEMBER/OCTOBER 2021;7(5):34-36
Beyer, K et al and IHE as part of the PIONEER Consortium The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer European Urology Focus, 2021; 7(5): 943-946
DOI: https://doi.org/10.1016/j.euf.2021.09.008
Tunis S, Hanna E, Neumann PJ, Toumi M, Dabbous O, Drummond M, Fricke F-U, Sullivan SD, Malone DC, Persson U, Chambers JD Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe Health Policy 2021; 125(12): 1550-1556
DOI: https://doi.org/10.1016/j.healthpol.2021.10.003
Persson U, Olofsson S, Gu N Y, Gong C L, Jiao X and Hay J W Health-related quality-of-life in the Swedish general population during COVID-19 based on pre- and post- pandemic outbreak measurements Nordic Journal of Health Economics, 2021; 9(1): 56-73
DOI: https://doi.org/10.5617/njhe.8332
Ringborg U, Berns A, Celis JE, Heitor M, et al. The Porto European cancer research summit 2021 Molecular Oncology, 2021; 15(10):2507-2543
DOI: https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13078
Vimefall E, Persson M, Olofsson S & Hultkrantz L Is prevention of suicide worth less? A comparison of the value per statistical life The European Journal of Health Economics, 2022; 23: 261–275
First online Aug 2021
DOI: https://doi.org/10.1007/s10198-021-01361-6
Hjalte F, Norlin JM, Kellerborg L, Odin P Parkinson’s disease in Sweden—resource use and costs by severity Acta Neurologica Scandinavica, 2021; 144(5): 592–599
DOI: 10.1111/ane.13502